Results 321 to 330 of about 14,230,992 (393)

Depletion of p75NTR in Schwann Cells Driven by Inflammation Mediates Cutaneous Pain in Psoriasis

open access: yesAdvanced Science, EarlyView.
Psoriasis‐like inflammation induces proliferation and molecular remodeling of cutaneous Schwann cells, marked by reduced p75NTR and increased NGF expression. IL‐17A promotes this process, whereas Schwann cell‐specific p75NTR overexpression alleviates cutaneous pain in vivo.
Yibo Wang   +9 more
wiley   +1 more source

Mineral coated microparticles delivering Interleukin-4, Interleukin-10, and Interleukin-13 reduce inflammation and improve function after spinal cord injury in a rat. [PDF]

open access: yesExp Neurol
Hellenbrand DJ   +13 more
europepmc   +1 more source

The interleukin-4/interleukin-13 pathway in type 2 inflammation in chronic rhinosinusitis with nasal polyps. [PDF]

open access: yesFront Immunol
Bachert C   +8 more
europepmc   +1 more source

Variation in Interleukin-4, -6, and -10 in Mastitis Milk: Associations with Infections, Pathogens, Somatic Cell Counts, and Oxidative Stress. [PDF]

open access: yesVet Sci
Chaisri W   +7 more
europepmc   +1 more source

Interleukin-4 downregulates transcription factor BCL6 to promote memory B cell selection in germinal centers. [PDF]

open access: yesImmunity
Shehata L   +7 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Interleukin-4 as a therapeutic target.

Pharmacology & Therapeutics, 2023
Interleukin-4 (IL-4) is a pleiotropic cytokine mainly known for its role in type 2 immunity. Therapies antagonizing or blocking IL-4 activity have been developed to counteract diseases such as atopic dermatitis and asthma.
Yvonne Gärtner   +3 more
semanticscholar   +3 more sources

Home - About - Disclaimer - Privacy